Charity Review: Stand Up To Cancer
Stand Up To Cancer fosters collaboration among top scientists across fields to speed up the translation of research findings into new treatments.
Genetic Testing for Cancer Risk: My Experience and What I Learned
What my experience with genetic testing was like and some of the helpful things I learned in the process.
Making a Difference: Contributing to Cancer Charities
We can make a difference in the fight against breast cancer by contributing to highly rated breast cancer and cancer research charities.
5 Cancer Research Stories Worth Following – Summer 2017
Two FDA approvals for immunotherapy treatments highlight cancer research news this summer. But the extremely high costs of new cancer therapies are yet to be addressed.
Blogging Challenge: My Answers to 10 Random Questions About Cancer
I’m taking up a blogging challenge in which participants are asked to give their answers to “10 random questions about cancer.”
Charity Review: Cancer Research Institute
The Cancer Research Institute fosters research in cancer immunology to develop more effective life-saving treatments for all types of cancer.
A Role for Progesterone in Breast Cancer Treatment?
New clinical trials will test whether the addition of progesterone could improve treatment for hormone receptor-positive breast cancer.
5 Cancer Research Stories Worth Following – Spring 2017
Cancer research stories worth following this spring include a study on the benefits of one type of immune system therapy for patients with metastatic triple negative breast cancer.
What is “Step Therapy” and Why Should We Care?
How is the practice of “step therapy” affecting patients?
Review of “The Gene: An Intimate History” by Siddhartha Mukherjee
In the next decade, we’re likely to know much more about our individual risks for a variety of diseases and conditions based on the information contained in our genomes.
5 Cancer Research Stories Worth Following – Winter 2017
Cancer research stories worth following this winter include a possible new use for an existing drug to prevent metastasis in triple negative breast cancer.
